首页> 外国专利> THERAPEUTIC COMBINATION OF AMLODIPINE AND BENAZEPRIL/BENAZEPRILAT

THERAPEUTIC COMBINATION OF AMLODIPINE AND BENAZEPRIL/BENAZEPRILAT

机译:阿糖胞苷与贝那普利/贝那普利的治疗性组合

摘要

The present invention especially relates to the use of a combination comprising;(1) an ACEI selected from the group consisting of benazepril, benazeprilat, and pharmaceutically acceptable salts thereof, and(2) amlodipine or pharmaceutically acceptable salt thereof, for the manufacture a medicament for the treatment or prevention or delay of progression of a condition selected from the group consisting of hypertension, congestive heart failure, angina, myocardial infarction, artherosclerosis, diabetic nephropathy, diabetic cardiac myopathy, renal insufficiency, peripheral vascular disease, left ventricular hypertrophy, cognitive dysfunction, blood pressure-related cerebrovasular disease, stroke, pulmonary disease or pulmonary hypertension and headache;wherein(i) the amount of amlodipine or a pharmaceutically acceptable salt thereof corresponds to 6 about mg to 40 about mg of the free base and(ii) the amount of the ACE inhibitor or a pharmaceutically thereof corresponds to 20 about mg to 160 about mg of benazepril hydrochloride.
机译:本发明尤其涉及包含以下的组合的用途:(1)选自苯那普利,贝那普利特及其药学上可接受的盐的ACEI,和(2)氨氯地平或其药学上可接受的盐,用于制造用于治疗或预防或延缓选自高血压,充血性心力衰竭,心绞痛,心肌梗塞,动脉硬化,糖尿病性肾病,糖尿病的疾病的药物心肌病,肾功能不全,周围血管疾病,左心室肥大,认知功能障碍,与血压有关的脑血管疾病,中风,肺部疾病或肺动脉高压和头痛;其中(i)氨氯地平或其药学上可接受的盐的量相当于6毫克至40毫克的游离碱;(ii)ACE抑制剂或其药学上的量相当于盐酸贝那普利的约20mg至160mg。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号